Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Use your intelligence to watch the competition

July 25, 2006 Research and Development, Sales and Marketing market research

One of the reasons the executives of ill-fated US energy group Enron were for a while 'the smartest guys in …
Feature

Roche surges on cancer drug sales

July 21, 2006 Sales and Marketing

Strong demand for Roche's cancer portfolio helped the Swiss pharma company grow at more than three times the industry rate …
News

Pfizer sets out on $17 billion acquisition trail

July 21, 2006 Sales and Marketing Pfizer

Pfizer, the world's biggest pharmaceutical company, has earmarked $17 billion to spend on new products and technologies over the next …
News

UK uptake of vaccine boosts Wyeth

July 21, 2006 Sales and Marketing

The long-awaited addition of Wyeth Prevnar to the UK's vaccination programme has helped the company increase revenues in the second …
News

Xeloda filed for advanced stomach cancer

July 21, 2006 Sales and Marketing

Roche has filed its drug Xeloda to treat patients with advanced stomach cancer, the second biggest cancer killer worldwide.The oral …
News

New licence allows patients to switch to Arimidex

July 14, 2006 Sales and Marketing

AstraZeneca has gained a new licence for its breast cancer drug Arimidex to allow patients to switch from tamoxifen after …
News

Tysabri returns with new safety precautions

July 13, 2006 Sales and Marketing

Multiple sclerosis drug Tysabri is set to be re-launched after overcoming serious concerns about its safety.Co-marketed by Elan and Biogen …
News

AstraZeneca and Abbott to develop combined lipid-targeting drug

July 13, 2006 Sales and Marketing

AstraZeneca and Abbott are to co-develop and market a combination treatment that will target three important blood lipids in one …
News

MabThera approved for rheumatoid arthritis

July 11, 2006 Sales and Marketing

Roche's blockbuster cancer drug MabThera has gained European marketing approval to treat rheumatoid arthritis.First launched in 1997, MabThera (rituximab) made …
News

Avastin filed for breast cancer treatment

July 10, 2006 Sales and Marketing

Roche's Avastin could be licensed to treat advanced breast cancer in Europe by early 2007, following its filing with regulator …
News

Company behind Northwick Park trial files for insolvency

July 7, 2006 Sales and Marketing

The pharmaceutical company behind TGN 1412, the drug which caused near-fatal reactions in six clinical trials volunteers at Northwick Park, …
News

Venomous snail provides Eisai with new painkiller

July 7, 2006 Research and Development, Sales and Marketing

Patients suffering severe chronic pain have new hope of relief thanks to a venomous sea snail found off the coast …
News

CRM and keeping up with your customers

July 6, 2006 Sales and Marketing CRM, customer relationship management, sales

Customer relationship management systems are now universally used by major pharmaceutical companies, in fact many have several.Evolving from their beginnings …
Feature

Patents: extending the golden years

July 5, 2006 Sales and Marketing patents, sales, strategy

Much like death and taxes, one of the certainties of this world is that patents expire, and if a product …
Feature

Hepatitis B treatment Baraclude approved in Europe

June 30, 2006 Sales and Marketing

A new hepatitis B treatment Baraclude has been approved in Europe and could eventually become a first-line choice thanks to …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026